Form 8-K - Current report:
SEC Accession No. 0001096906-23-001206
Filing Date
2023-05-30
Accepted
2023-05-30 15:50:28
Documents
15
Period of Report
2023-05-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING axim-20230523.htm   iXBRL 8-K 22417
2 FORM OF THE CONVERTIBLE NOTES DATED MAY 23, 2023 axim_ex10z1.htm EX-10.1 28368
7 IMAGE axim8k_1.jpg GRAPHIC 4297
  Complete submission text file 0001096906-23-001206.txt   202468

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20230523_def.xml EX-101.DEF 1842
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20230523_lab.xml EX-101.LAB 20878
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20230523_pre.xml EX-101.PRE 13908
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20230523.xsd EX-101.SCH 2382
9 EXTRACTED XBRL INSTANCE DOCUMENT axim-20230523_htm.xml XML 2446
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 23976071
SIC: 2834 Pharmaceutical Preparations